Historical shareholding details of Oberweis Asset Management Inc holdings in Haemonetics Corp. (HAE)

Monthly changes of Oberweis Asset Management Inc shareholding in Haemonetics Corp. over the previous months

Month Name Total no. shares held Percent Holding
Mar 31, 2025 Oberweis Asset Management Inc 430,600 0.86%
Feb 28, 2025 Oberweis Asset Management Inc 430,600 0.86%
Jan 31, 2025 Oberweis Asset Management Inc 335,200 0.67%
Dec 31, 2024 Oberweis Asset Management Inc 224,920 0.45%
Dec 31, 2024 Oberweis Asset Management Inc 335,200 0.67%
Nov 30, 2024 Oberweis Asset Management Inc 335,200 0.67%
Oct 31, 2024 Oberweis Asset Management Inc 310,200 0.62%
Sep 30, 2024 Oberweis Asset Management Inc 177,795 0.35%
Sep 30, 2024 Oberweis Asset Management Inc 310,200 0.61%
Aug 31, 2024 Oberweis Asset Management Inc 310,200 0.61%
Jul 31, 2024 Oberweis Asset Management Inc 289,000 0.57%
Jun 30, 2024 Oberweis Asset Management Inc 165,295 0.33%
Jun 30, 2024 Oberweis Asset Management Inc 267,800 0.53%
May 31, 2024 Oberweis Asset Management Inc 267,800 0.53%
Apr 30, 2024 Oberweis Asset Management Inc 193,400 0.38%
Mar 31, 2024 Oberweis Asset Management Inc 143,695 0.28%
Mar 31, 2024 Oberweis Asset Management Inc 193,400 0.38%
Feb 29, 2024 Oberweis Asset Management Inc 193,400 0.38%
Jan 31, 2024 Oberweis Asset Management Inc 154,800 0.31%
Dec 31, 2023 Oberweis Asset Management Inc 154,800 0.31%
Nov 30, 2023 Oberweis Asset Management Inc 124,900 0.25%
Oct 31, 2023 Oberweis Asset Management Inc 124,900 0.25%
Sep 30, 2023 Oberweis Asset Management Inc 77,400 0.15%
Sep 30, 2023 Oberweis Asset Management Inc 95,000 0.19%
Aug 31, 2023 Oberweis Asset Management Inc 84,400 0.17%
Jul 31, 2023 Oberweis Asset Management Inc 73,800 0.15%
Jun 30, 2023 Oberweis Asset Management Inc 47,500 0.09%
Jun 30, 2023 Oberweis Asset Management Inc 73,800 0.15%
May 31, 2023 Oberweis Asset Management Inc 39,400 0.08%
Mar 31, 2023 Oberweis Asset Management Inc 36,900 0.07%
Dec 31, 2022 Oberweis Asset Management Inc 19,700 0.04%

View all ownership details of Haemonetics Corp.